Ricky Zipp

A Boston Scientific spokesperson said the company still expects to close its $1.26 billion purchase of Silk Road Medical in the second half of the year.

Que Dallara, president of Medtronic’s diabetes unit, said the company still believes in its diabetes technology, but the partnership “allows us to tap into the largest CGM install base in the world.”

Getinge will pay $253 million in cash at closing, with additional payments expected to be made between 2024 and 2026 if certain milestones are met.

Johnson & Johnson did not provide Auris Health with resources to achieve regulatory milestones after acquiring the robotics company in 2019, the judge found.

Silk Road Medical said in a securities filing that the antitrust waiting period expired Thursday evening, opening the door to complete the $1.26 billion deal.

Older medical devices with unsupported software pose cybersecurity threats that regulators and industry are struggling to solve. Here are four steps experts say can help mitigate risks.

As hospitals around the U.S. report IV fluid shortages, Baxter has increased supply allocations for direct customers and distributors. It plans to return to 90% to 100% allocation of certain supplies by the end of 2024.

B. Braun and Fresenius Medical Care said they will make more crucial products as the U.S. faces shortages following Hurricane Helene’s damage to a Baxter manufacturing facility.

Johnson & Johnson’s medtech acquisitions over the past year have fueled growth for its cardiovascular group, offsetting challenges in businesses like orthopedics and surgery.

Robert Ford’s comments come as new CGMs and insulin pumps continue to roll out in the diabetes tech space, including over-the-counter glucose sensors.